Indications Indications for<unk>  are as follows: Hematologic Malignancies Tumors * Acute myeloid leukemia (AML) * chronic-phase chronic myeloid leukemia (CP-CML) * Myelodysplastic syndromes (MDS) * Intermediate- or high-risk Non-Hodgkin lymphoma * High-risk Hodgkin lymphoma * Multiplemyeloma (MM) * Severe aplastic anemia (SAA) Stem cell sources The cells employed are allogeneic peripheral blood stem cells. Matched HLA between donor and recipient is not necessary. The stem cells are collected from donor’s blood through a process known as apheresis after a certain period of daily subcutaneous injections of Granulocyte-colony stimulating factor, serving to mobilize stem cells from the donor's bone marrow into the peripheral circulation. Fresh cells are infused to recipient for the first time, and then stored in a controlled-rate freezer. Donor’s Requirements: * Mismatched HLA with recipient * Age between 18 and 60 years old * Good overall state of health * No major heart or lung surgical history * No infectious diseases such as HIV, hepatitis or syphilis, etc. * No bone marrow disorder, high blood pressure, coronary heart disease, cardiopulmonary insufficiency, hematological disorder or tumor * Not allergic to G-CSF * Not pregnant or lactating
Microtransplantation
Xenotransplantation
Autotransplantation
Allotransplantation
Replantation
Cell therapy
Tissue engineering
Neural tissue engineering